In turnaround, Solid Bio reports promising initial data for Duchenne gene therapy
Solid Biosciences reported that three children with Duchenne muscular dystrophy who received its gene therapy saw high levels of a key muscle protein called microdystrophin in a clinical trial. The biotech
Solid Biosciences reported that three children with Duchenne muscular dystrophy who received its gene therapy saw high levels of a key muscle protein called microdystrophin in a clinical trial.
The biotech
